Biventricular pacing for atrioventricular block and systolic dysfunction.
Anne B Curtis, Seth J Worley, Philip B Adamson...
https://pubmed.ncbi.nlm.nih.gov/23614585/Actively Recruiting
Led by Yonsei University · Updated on 2026-01-05
450
Participants Needed
8
Research Sites
N/A
Total Duration
Researchers are evaluating clinical outcomes in patients with bradyarrhythmia who require a high amount of ventricular pacing over 40%. This trial compares Left Bundle Branch Area Pacing LBBAP with Right Ventricular Pacing RVP to see if LBBAP reduces risks such as death, heart failure progression, pacing-induced cardiomyopathy, and the need for cardiac resynchronization therapy. The study is conducted across seven medical centers in the Republic of Korea with a total enrollment of 450 patients. Patients needing a pacemaker and significant ventricular pacing will be randomly assigned to receive either LBBAP or RVP. In the LBBAP group, a specialized lead is placed at the left bundle branch area of the heart, while in the RVP group, the lead is placed in the right ventricle using standard methods. The study includes a 2-year enrollment period followed by 2 years of patient follow-up to assess outcomes. Participants will undergo pacemaker implantation and then be monitored for 2 years, with evaluations including death rates, heart failure hospitalizations, device complications, and heart function tests. Success rates and complications related to LBBAP are tracked, along with measurements of left ventricular function and exercise capacity. Researchers will also monitor for incidental atrial fibrillation and other cardiovascular events during follow-up.
CONDITIONS
PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial
T
TaeHoon Kim
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Yonsei University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure day plus initial recovery period
Participants receive either left bundle branch area pacing (LBBAP) or right ventricular pacing (RVP) as part of their pacemaker implantation procedure.
1 baseline implantation visit and approximately 1 week of monitoring visits
Duration - Up to 2 years
Participants are monitored for up to 2 years after pacemaker implantation to assess health outcomes, device success, and any complications.
Multiple follow-up visits over 2 years, including assessments at 6 months and 2 years
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Anne B Curtis, Seth J Worley, Philip B Adamson...
https://pubmed.ncbi.nlm.nih.gov/23614585/Fred M Kusumoto, Mark H Schoenfeld, Coletta Barrett...
https://pubmed.ncbi.nlm.nih.gov/30586772/Michael O Sweeney, Anne S Hellkamp, Kenneth A Ellenbogen...
https://pubmed.ncbi.nlm.nih.gov/12782566/Mohamed Abdelrahman, Faiz A Subzposh, Dominik Beer...
https://pubmed.ncbi.nlm.nih.gov/29535066/H F Tse, C P Lau
https://pubmed.ncbi.nlm.nih.gov/9091519/Weijian Huang, Lan Su, Shengjie Wu...
https://pubmed.ncbi.nlm.nih.gov/30093543/Pugazhendhi Vijayaraman, ShunmugaSundaram Ponnusamy, Óscar Cano...
https://pubmed.ncbi.nlm.nih.gov/33602393/Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg...
https://pubmed.ncbi.nlm.nih.gov/34455430/Parikshit S Sharma, Neil R Patel, Venkatesh Ravi...
https://pubmed.ncbi.nlm.nih.gov/34481985/Bruce L Wilkoff, James R Cook, Andrew E Epstein...
https://pubmed.ncbi.nlm.nih.gov/12495391/Yonsei University
Lead Sponsor